Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Pharmarise Holdings Corp. ( (JP:2796) ) has issued an announcement.
Pharmarise Holdings Corporation reported a significant increase in its financial performance for the first three months of the fiscal year ending May 31, 2026, with net sales rising by 10% year-on-year. Despite a net loss attributable to owners of the parent, the company achieved substantial growth in operating and ordinary profit, indicating improved operational efficiency and market positioning. The company’s financial outlook for the fiscal year remains positive, with expected growth in net sales and profits, reflecting its strategic focus on enhancing shareholder value.
The most recent analyst rating on (JP:2796) stock is a Hold with a Yen520.00 price target. To see the full list of analyst forecasts on Pharmarise Holdings Corp. stock, see the JP:2796 Stock Forecast page.
More about Pharmarise Holdings Corp.
Pharmarise Holdings Corporation operates in the pharmaceutical industry, focusing on the development, production, and distribution of pharmaceutical products. The company is listed on the Tokyo Stock Exchange and is known for its commitment to innovation and quality in healthcare solutions.
Average Trading Volume: 10,332
Technical Sentiment Signal: Hold
Current Market Cap: Yen6.14B
Learn more about 2796 stock on TipRanks’ Stock Analysis page.